Medicure Inc. 2023 Investor Presentation

Medicure is a profitable specialty pharmaceutical company focused on the US market with core products AGGRASTAT and ZYPITAMAG. The company operates Marley Drug e-commerce pharmacy and has MC-1 in phase 3 development with priority review voucher, maintaining a debt-free balance sheet.